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Abstracts / Urological Science 26 (2015) S1eS25S20Purpose: Evaluate the safety and efﬁcacy of radiofrequency ablation (RFA)
in treating aldosteronism producing adenoma (APA) of adrenal gland.
Materials and Methods:We retrospective evaluated a patient cohort with
computed tomography (CT) - guided percutaneous RFA performed on APA
of size 2.5 cm or less. Treatment success was deﬁned as complete tumor
ablation on follow-up CT scan plus normalization of serum aldosterone-to-
renin ratio. We also made comparison of “normalization ability” with
previous conventional LA for APA. The normalization ability was deﬁned as
reduction amount of blood pressure, number of hypertensive medicine
use, aldosterone level, and increased in potassium level.
Results: Between September 2009 till September 2013, 25 patients were
included with the diagnosis of unilateral APA, 7 underwent RFA and 18
underwent LA. The tumor sizes ranged from 8-25 mm. There was one
intra-procedure HTN crisis during RFA. Both groups presented no com-
plications which need further management. During a 3 to 6 months fol-
lowed up, total response rate reached 100% in RFA group versus 94.4% in LA
group. Normalization ability was statistical equivalent between RFA and LA
group.
Conclusion: CT- guided percutaneous RFA is efﬁcatious and safe in treating
APA. It is a justiﬁable alternative for patients who are reluctant or unﬁt for
surgery.
PD11-3:
HYDROSTATIC PRESSURE ENHANCES MITOMYCIN C INDUCED APOPTOSIS
IN UROTHELIAL CARCINOMA CELLS
Shao Kuan Chen. Sijhih Cathay General Hospital, Taiwan
Purpose: Urothelial carcinoma (UC) of the bladder is the second most
common cancer of the genitourinary system. Clinical UC treatment usually
involves transurethral resection of the bladder tumor (TURBT) followed by
adjuvant intravesical immunotherapy or chemotherapy to prevent recur-
rence. Intravesical chemotherapy induces fewer side effects than immu-
notherapy but is less effective at preventing tumor recurrence.
Improvement to intravesical chemotherapy is, therefore, needed.,
Materials and Methods: The cellular effects of mitomycin C (MMC) and
hydrostatic pressure on UC BFTC905 cells were assessed. Viability of the UC
cells was determined using cellular proliferation assay. Changes in
apoptotic function were evaluated by caspase 3/7 activities, expression of
FasL, and loss of mitochondrial membrane potential.
Results: Reduced cell viability was associated with increasing hydrostatic
pressure. Caspase 3/7 activities were increased following treatment of the
UC cells with MMC or hydrostatic pressure. In combination with 10 kPa
hydrostatic pressure, MMC treatment induced increasing FasL expression.
The mitochondria of UC cells displayed increasingly impaired membrane
potentials following combined treatment with 10 mg/mL MMC and 10 kPa
hydrostatic pressure.
Conclusion: Both MMC and hydrostatic pressure can induce apoptosis in
UC cells through an extrinsic pathway. Hydrostatic pressure speciﬁcally
increases MMC-induced apoptosis and might minimize the side effects of
the chemotherapy by reducing the concentration of the chemical agent.
This study provides a new and alternative approach for treatment of UC
patients following TURBT.
PD11-4:
ARSENIC EXPOSURE AND TEMPORAL TREND OF INCIDENCE IN UPPER
URINARY TRACT UROTHELIAL CARCINOMA, 1979-2010: A NATIONWIDE
POPULATION-BASED STUDY IN TAIWAN
Yi-Sheng Tai 1, Chao-Yuan Huang 2, Huai-Chin Tai 2, So-Mong
Wang 2, Yeong-Shiau Pu 2, Chung-Hsin Chen 2. 1Department of Urology,
National Taiwan University Hospital, Yun-Lin Branch, Taiwan; 2Department
of Urology, National Taiwan University Hospital, Taiwan
Purpose: To investigate the newly diagnosed incidence of arsenic (AS)-
related upper urinary tract urothelial carcinoma (UTUC) in Taiwan
Materials andMethods: From1979 through 2010, patientswithUTUCwere
extracted from Taiwan Cancer Registry Database. According to birth resi-
dency, the patients were further divided into 4 areas, including the zone
0 (Z0) (awellwater AS level of less than350 ng/ml andnoblackfoot disease),
zone 1 (Z1) (a well water AS level of 350 ng/ml or greater and no blackfootdisease), zone 2 (Z2) (a well water arsenic level of less than 350 ng/ml with
sporadic blackfoot or AS-related skin diseases ) and the zone 3 (Z3) (a well
water AS level of 350 or greater and the blackfoot disease endemic area). The
temporal trends for newly diagnosed rate were analyzed by linear regres-
sion. The incidences between groups were compared using Friedman's
ANOVA. A p value of < 0.05 was considered statistically signiﬁcant.
Results: A total of 19,226 patients with newly diagnosed UTUC were
identiﬁed, including 10,404 (54.1%) women and 8822 (45.9%) men. In 2010,
the overall newly diagnosed rates of UTUC stratiﬁed by sex were 4.53%,
6.55%, 9.23% and 8.57% (female) as well as 4.35%, 4.95%, 5.75% and 9.28%
(male) in Z0, Z1, Z2 and Z3, respectively. The trends of annual newly
diagnosed incidences in the 4 areas increase from 1979 to 2010. People in
Z3 area have signiﬁcantly annual raising rate of incidence than those in Z0,
Z1 and Z2 (female: 0.31% vs. 0.17%, 0.23% and 0.24%, p< 0.001; male: 0.25%
vs 0.13%, 0.17% and 0.14%).
Conclusion: The overall incidence of UTUC in Taiwan is increasing from
1979 to 2010. People who lived in the high arsenic endemic area (Z3) had
higher incidence of UTUC than people lived in other areas of Taiwan.
PD11-5:
GLYCOLYSIS PROMOTINGCANCERSTEMCELLPHENOTYPEAND INDUCING
EPITHELIAL-MESENCHYMAL TRANSITION
G.-S. Shieh 1, W.-H. Yang 2, C.-L. Wu 3, A.-L. Shiau 4. 1 Tainan Hospital, Dept.
of Urology, Tainan, Taiwan; 2National Cheng Kung University Hospital, Dept.
of Urology, Tainan, Taiwan; 3National Cheng Kung University Hospital, Dept.
of Biochemistry and Molecular Biology, Tainan, Taiwan; 4National Cheng
Kung University Hospital, Dept. of Microbiology and Immunology, Tainan,
Taiwan
Purpose: Cancer stem cells were considered to be the genesis of cancer
and account for cancer initiation, progression, and recurrence. Hexokinase
2 (HK2) catalyzed the ﬁrst irreversible step of glycolysis andwas associated
with poor outcomes in cancer patients. Studies have highlighted a role for
HK2 in facilitating tumor growth and lactate production, which is down-
stream product of HK2 reaction in cancer cells. Tumor cells can extrude
and shuttle lactate to neighboring cancer cells, adjacent stromal cells, and
vascular endothelial cells to induce signaling molecular change. However,
in tumor microenvironment, the molecular mechanisms underlying this
association of tumor lactate shuttle, HK2 activity and cancer metastases
were not well established. In this study, we assessed the contribution of
HK2 expression in human bladder cancer samples and the association of
survival data, and explored the role of lactate shuttle induced by HK2 in
cancer stem cell formation and epithelial-mesenchymal transition (EMT)
between bladder cancer cells in vitro and in vivo.
Materials and Methods: We examined HK2 expression by immunohis-
tochemistry in tumors (n ¼ 151) and normal specimens (n ¼ 20) from
bladder cancer patients. The association of HK2 with survival and patho-
logical characteristics was assessed using Kaplan-Meier survival curves
and two-sided chi-square test. Endogenous HK2 in human bladder cancer
(TCCSUP, J82 and TSGH8301) and normal (SVHUC) cells was examined by
immunoblot and immunoﬂuoscence. Effects of HK2 overexpression on cell
proliferation, morphologic change and cancer stem cell phenotype were
analyzed in human bladder cancer TSGH8301 and TCCSUP cells. Stable
HK2-overexpression clones were also examined for their effects on EMT,
NF-kB phosphorylation and CD133 activity in vitro and mouse models. The
animal survival and lung metastasis were assessed in a mouse subcu-
taneous model using TSGH8301 cells with HK2-overexpression clones. All
statistical tests were two-sided.
Results: The HK2 expression was signiﬁcantly higher in bladder cancers
compared with normal tissues. In human bladder cancer samples, 54.1%
and 45.9% showed positive and negative HK2 expression, respectively. The
urine lactate detection was higher in human bladder cancers than in non-
cancer subjects (204.9 vs 54.79 mM; P < 0.001). Stable HK2 overexpression
induced cell proliferation, and showed morphologic changes with gain of
cancer stem cell markers. HK2 Knockdown also reduced lactate extrusion
in vitro. In response to lactate exposure, nuclear translocation of NF-kB
phosphorylation and Twist1 as well as mesenchymal markers was pro-
moted in human bladder cancer cells. In addition, lactate exposure
enhanced CD133 activity in vitro. In mice bearing subcutaneous tumors,
increased tumor growth and lung metastasis were observed in stable HK2-
